FFA
ALNY icon

Farther Finance Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Farther Finance Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$391K Buy
1,583
+437
+38% +$111K ﹤0.01% 1794
2026
Q2 		$345K Buy
1,146
+236
+26% +$71.2K ﹤0.01% 1844
2026
Q1 		$299K Sell
910
-325
-26% -$111K ﹤0.01% 1733
2025
Q4 		$491K Buy
1,235
+507
+70% +$224K 0.01% 1321
2025
Q3 		$332K Buy
728
+349
+92% +$142K 0.01% 1327
2025
Q2 		$123K Buy
379
+138
+57% +$38.2K ﹤0.01% 1655
2025
Q1 		$61.6K Hold
241
– – ﹤0.01% 1795
2024
Q4 		$56.8K Buy
241
+30
+14% +$7.89K ﹤0.01% 1595
2024
Q3 		$58.1K Buy
211
+103
+95% +$26.8K ﹤0.01% 1570
2024
Q2 		$26.3K Buy
108
+39
+57% +$6.16K ﹤0.01% 1680
2024
Q1 		$10.6K Sell
69
-25
-27% -$4.17K ﹤0.01% 1743
2023
Q4 		$18K Buy
94
+69
+276% +$11.8K ﹤0.01% 1365
2023
Q3 		$4.43K Buy
25
+4
+19% +$763 ﹤0.01% 1552
2023
Q2 		$3.99K Buy
21
+5
+31% +$991 ﹤0.01% 1508
2023
Q1 		$3.21K Hold
16
– – ﹤0.01% 1466
2022
Q4 		$3.8K Buy
+16
New +$3.41K ﹤0.01% 1260

Other funds holding ALNY

MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
LJHT
Laurie J. Hall Trustee $314M AUM 27.43% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
BFS
Burkett Financial Services Rock Hill, South Carolina $331M AUM 14.93% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Farther Finance Advisors's ALNY Position: Q3 2026 in Review

Farther Finance Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 38% in Q3 2026, buying an estimated $111K and bringing the position to 1,583 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #1794.

Farther Finance Advisors first reported a position in ALNY in Q4 2022 and has held it in 16 quarters since. The position peaked at $491K in Q4 2025. 19 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Farther Finance Advisors held 1,583 shares of Alnylam Pharmaceuticals worth $391K as of Q3 2026.
  • Farther Finance Advisors bought 437 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $111K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #1794 holding.
  • Farther Finance Advisors first reported a position in Alnylam Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's Alnylam Pharmaceuticals position peaked at $491K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.